Literature DB >> 20140487

Sexual orientation versus age of onset as bases for typologies (subtypes) for gender identity disorder in adolescents and adults.

Anne A Lawrence1.   

Abstract

The most widely used and influential typologies for transsexualism and gender identity disorder (GID) in adolescents and adults employ either sexual orientation or age of onset of GID-related symptoms as bases for categorization. This review compares these two typological approaches, with the goal of determining which one should be employed for the diagnosis of GID in Adolescents or Adults (or its successor diagnosis) in the forthcoming revision of the Diagnostic and Statistical Manual of Mental Disorders (DSM). Typologies based on sexual orientation and age of onset of GID-related symptoms are roughly comparable in ease and reliability of subtype assignment. Typologies based on sexual orientation, however, employ subtypes that are less ambiguous and better suited to objective confirmation and that offer more concise, comprehensive clinical description. Typologies based on sexual orientation are also superior in their ability to predict treatment-related outcomes and comorbid psychopathology and to facilitate research. Commonly expressed objections to typologies based on sexual orientation are unpersuasive when examined closely. The DSM should continue to employ subtypes based on sexual orientation for the diagnosis of GID in Adolescents or Adults or its successor diagnosis.

Entities:  

Mesh:

Year:  2010        PMID: 20140487     DOI: 10.1007/s10508-009-9594-3

Source DB:  PubMed          Journal:  Arch Sex Behav        ISSN: 0004-0002


  14 in total

Review 1.  To treat or not to treat: puberty suppression in childhood-onset gender dysphoria.

Authors:  Rosalia Costa; Polly Carmichael; Marco Colizzi
Journal:  Nat Rev Urol       Date:  2016-07-19       Impact factor: 14.432

2.  [Surgical gender reassignment in the elderly].

Authors:  R Rossi Neto; F Vom Dorp; M Schenck; H Rübben; J Hess
Journal:  Urologe A       Date:  2012-10       Impact factor: 0.639

Review 3.  Challenges in assessing personality of individuals with Gender Dysphoria with the SWAP-200.

Authors:  V Lingiardi; G Giovanardi
Journal:  J Endocrinol Invest       Date:  2017-02-25       Impact factor: 4.256

4.  Male-typical visuospatial functioning in gynephilic girls with gender dysphoria - organizational and activational effects of testosterone.

Authors:  Sarah M Burke; Baudewijntje P C Kreukels; Peggy T Cohen-Kettenis; Dick J Veltman; Daniel T Klink; Julie Bakker
Journal:  J Psychiatry Neurosci       Date:  2016-10       Impact factor: 6.186

5.  Brief report: female-to-male transsexual people and autistic traits.

Authors:  Rebecca M Jones; Sally Wheelwright; Krista Farrell; Emma Martin; Richard Green; Domenico Di Ceglie; Simon Baron-Cohen
Journal:  J Autism Dev Disord       Date:  2012-02

6.  Sociodemographic Study of Danish Individuals Diagnosed with Transsexualism.

Authors:  Rikke Simonsen; Gert Martin Hald; Annamaria Giraldi; Ellids Kristensen
Journal:  Sex Med       Date:  2015-06       Impact factor: 2.491

7.  Hypothalamic response to the chemo-signal androstadienone in gender dysphoric children and adolescents.

Authors:  Sarah M Burke; Peggy T Cohen-Kettenis; Dick J Veltman; Daniel T Klink; Julie Bakker
Journal:  Front Endocrinol (Lausanne)       Date:  2014-05-28       Impact factor: 5.555

Review 8.  Gender identity and autism spectrum disorders.

Authors:  Gerrit I van Schalkwyk; Katherine Klingensmith; Fred R Volkmar
Journal:  Yale J Biol Med       Date:  2015-03-04

9.  Body Satisfaction and Physical Appearance in Gender Dysphoria.

Authors:  Tim C van de Grift; Peggy T Cohen-Kettenis; Thomas D Steensma; Griet De Cuypere; Hertha Richter-Appelt; Ira R H Haraldsen; Rieky E G Dikmans; Susanne C Cerwenka; Baudewijntje P C Kreukels
Journal:  Arch Sex Behav       Date:  2015-10-16

10.  Structural connections in the brain in relation to gender identity and sexual orientation.

Authors:  Sarah M Burke; Amir H Manzouri; Ivanka Savic
Journal:  Sci Rep       Date:  2017-12-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.